Macro Dashboard
| Indicator | Value | 5-Day Change | Signal |
|---|---|---|---|
| KOSPI | 6,035.4 | −13.1% | Bear |
| KOSDAQ | 837.0 | −9.0% | Bear |
| VIX | 15.6 | +3.3% | Stable |
| US 10Y | 5.24% | −0.03pp | Neutral |
| USD/KRW | 1,340 | +0.1% | Neutral |
| Brent | $104.7 | +0.4% | Stable |
Regime: Korea = Bear · US = Bull · Stance: reduce KR, hold US.
KOSPI breadth remains compressed — 39% of names above the 50-day MA, 23% above the 200-day MA. Program selling dominated: market program flow was −₩2.06 trillion on the day, ETF net creation −₩1.53 trillion. Basis held at +2.73, but the derivative/passive pressure is the primary KR bear driver, not a macro shock. The KR-US regime split is confirmed and widening.
Market Wrap
Source: KR Market Snapshot (same-day DB, 2026-10-13). No full close briefing was available; a prior-session briefing was intentionally excluded.
Today was another broad retreat. Of 2,595 listed names, 1,737 fell and only 613 advanced — an advance-decline ratio of 35.3. The average stock dropped 1.04%. The session had no dominant sector story; it was program-led index pressure pulling the tape lower across the board.
What held: Institutions stepped in selectively on large-cap names. LG Energy Solution (373220.KS, +3.0%), SK Innovation (096770.KS, +2.6%), and Meritz Financial Group (138040.KS, +2.2%) closed higher. HPSP (403870.KQ, +0.9%) and DB Non-Life Insurance (005830.KS, +0.9%) also closed green.
What was hit: Consumer beauty and mid-cap domestic themes absorbed the most selling. Pharma Research (214450.KQ, −8.1%), Korea Kolmar (161890.KS, −7.7%), Silicon2 (257720.KQ, −6.7%), and SK (034730.KS, −7.4%) led declines.
Foreign flow: Scattered and counter-trend. Foreigners net-bought VM (089970.KQ), Pharma Research (214450.KQ), and Samhwa Capacitor (001820.KS) even as prices fell — position-building into weakness rather than momentum. They were net sellers of LG Energy Solution (373220.KS), KB Financial (105560.KS), and SK (034730.KS).
Institutional flow: Institutions bought LG Energy Solution, Hyundai Motor (005380.KS), KB Financial, and HPSP against the tape — consistent with benchmark rebalancing rather than fresh conviction. They sold VM, Silicon2, Pharma Research, and Samhwa Capacitor, creating a clean institutional-vs-foreign split in mid-cap names where the two investor types took opposite sides of the same stocks.
The key signal is the OI increase of +13,424 contracts alongside heavy program selling — consistent with index futures hedging, not directional shorting. Until program flows normalize, individual stock selectivity remains the better approach over broad index exposure.
Today’s Quality Re-Rating Candidates
Primary source: KR Meta Screener, 2026-10-13. PEAD screener latest available: 2026-10-09 (same-day PEAD output absent; meta screener marks PEAD as empty). Screener intersection shows no 2+ raw overlaps today, so Meta Screener rank and evidence-family count drive candidate order.
Despite the broad decline, the screening framework identifies names where institutional and foreign money is absorbing retail supply — the foundational setup for quality re-rating. The top candidates combine at least two independent evidence families: fundamental quality, smart money flow, earnings/cycle momentum, or official DART catalyst.
Candidate Table
| Rank | Ticker | Name | Meta Score | Screeners / Evidence Signals | Key Metrics | DART |
|---|---|---|---|---|---|---|
| 1 | 098120.KQ | Micro Contact Sol | 56.6 | Quality + Smart Money Q + Cycle Rerating + Smart Money Earnings + Surface | ROE 23.1%, OP YoY +73.5%, margin +3.0pp | 1 filing |
| 2 | 252990.KQ | SamC&S | 52.2 | Quality + Cycle Rerating + Surface | ROE 9.7%, OP YoY +182.7%, margin +9.1pp | None |
| 3 | 096530.KQ | Seegene | 51.0 | Quality + Cycle Rerating + Surface | ROE 4.8%, OP YoY +309.7%, margin +11.3pp | 1 catalyst |
| 4 | 028670.KS | Pan Ocean | 49.8 | Smart Money Q + Smart Money Earnings + RS80 + Surface | 5-day F+QI net +₩21.4bn, retail −₩19.5bn | 2 catalysts |
| 5 | 033780.KS | KT&G | 49.1 | Quality + RS80 + Surface | ROE 11.7%, OP YoY +13.0%, foreign ownership 51.2% | 2 catalysts (buyback + cancellation) |
| 6 | 204620.KQ | Global Tax Free | 49.0 | Quality + RS80 + Surface | ROE 27.8%, OP YoY +34.3%, pivot gap +6.0% | 2 filings |
| 7 | 443060.KS | HD Hyundai Marine Solution | 44.4 | Quality + Cycle Rerating + Surface | ROE 33.7%, OP YoY +28.9%, margin +2.1pp | 1 catalyst (IR) |
| 8 | 025560.KS | Mirae Industry | 43.1 | Quality + Surface | ROE 8.8%, OP YoY −24.8% | 2 supply contracts |
| 9 | 353200.KQ | Daeduck Electronics | 40.6 | Smart Money Q + Cycle Rerating + Smart Money Earnings + Surface | 5-day F+QI net +₩17.6bn, retail −₩31.6bn | 1 filing |
| 10 | 219130.KQ | Tiger Elec | 38.0 | Quality + Surface | ROE 9.5%, OP YoY flat | None |
Top 3 in Focus
#1 — Micro Contact Sol (098120.KQ) makes semiconductor test sockets — the precision contact hardware used in chip testing at IC manufacturers. It is the only name in today’s screen that fires all five signal families simultaneously: Quality Compounder (ROE 23.1%, OP up 73.5% YoY, margin expansion +3.0pp), Smart Money Quality (foreigners and quality institutions net-absorbed ₩7.8bn over 5 days while individuals sold ₩9.2bn), Cycle Rerating, Smart Money Earnings, and Kiwoom market surface confirmation. The PEAD screener from Oct 9 also places it in Tier A with a 73.5% OP beat — cross-validation across two independent data pipelines. DART has one filing: an executive shareholding disclosure on Oct 8 (neutral). Next check: whether the OP beat is driven by volume ramp or unit pricing improvement, and whether sell-side consensus has revised forward estimates upward following the most recent quarter.
#2 — SamC&S (252990.KQ) is a semiconductor materials and components supplier. The +182.7% OP YoY growth and +9.1pp margin expansion are the largest margin inflection numbers in today’s top 10. Cycle Rerating and Quality Compounder both fire. The Kiwoom surface shows institutional accumulation (rank #439 by institutional count), foreigners net buying, program flow +7.4%, and short interest at a low 2.8% — relatively clean positioning with little technical overhead. No DART filings in the 21-day lookback window. Next check: what is driving the OP surge — structural (new contract mix, capacity utilization) or one-time — and whether the margin expansion is repeatable at current revenue levels.
#3 — Seegene (096530.KQ) is Korea’s leading molecular diagnostics platform, most recognized for its COVID-era revenue surge. The OP YoY of +309.7% is a base-effect comparison, so the more durable data point is the +11.3pp margin expansion. Individuals sold ₩15.4bn while foreigners and quality institutions absorbed supply, and the Kiwoom surface confirms positive institutional and financial investor flow. A DART catalyst is on record: Q3 interim dividend record date (Sep 28), adding a shareholder-return signal. Caution flags apply: short interest is elevated at 7.3%, program flow at +18.4% is passive-driven rather than conviction buying, the order book shows a +59% bid-ask imbalance, and the foreign broker channel was net-selling. This is a screened candidate, not a clean setup — position sizing and entry timing require additional verification. Next check: revenue trajectory in diagnostics excluding COVID kits, and any new product cycle in molecular or AI-assisted pathology.
Notable Beyond the Top 3
Pan Ocean (028670.KS) carries 6 independent evidence signals — the highest count in today’s screen — combining Smart Money Quality, Smart Money Earnings, RS80 leadership (Focus Candidate, pivot gap +1.7%), and two DART supply contract catalysts (Oct 1 and Sep 28). However, the foreign-vs-institutional flow split is inverted: foreigners are net sellers while quality institutions are buying. Short interest at 7.1% is also not trivial. The 6-signal convergence warrants attention, but the flow divergence needs a clean read before treating this as a straightforward accumulation setup.
KT&G (033780.KS) adds a shareholder return angle rarely seen in a bear-regime session. DART records both a share repurchase decision and a treasury stock cancellation (both Sep 22 catalysts). With 51.2% foreign ownership already near capacity, the marginal catalyst is float compression from the buyback, not new foreign entry. Quality Compounder and RS80 Not-Late both confirm, and quality-institution flow is positive — worth monitoring for a bottoming signal if the broader bear regime begins to lift.
All data sourced from Research OS internal screeners as of 2026-10-13. This post is public market analysis only and does not constitute investment advice.